Stock Value
About Calithera Biosciences
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business.
History
Calithera Biosciences, Inc. was founded in 2010. The company was incorporated in the state of Delaware in 2010.
Country
Founded:
2010
IPO Date:
10/03/2014
ISIN Number:
I_US13089P5070
Contact Details
Address:
343 Oyster Point Boulevard, Suite 200, South San Francisco, California, 94080, United States
Phone Number
650 870 1000
Key Executives
CEO:
Data Unavailable
CFO
Wong, Stephanie
COO:
Data Unavailable
